EUVIMEDEUVIMED entdecken
Open Access

Development of tryptophan metabolism patterns to predict prognosis and immunotherapeutic responses in hepatocellular carcinoma

Guo Long, Dong Wang, Jianing Tang, Weifeng Tang

Aging · 2023

DOI: 10.18632/aging.204928 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Guo Long und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tryptophan metabolism is associated with tumorigenesis and tumor immune response in various cancers. Liver is the main place where tryptophan catabolism is performed. However, the role of tryptophan metabolism in hepatocellular carcinoma (HCC) has not been well clarified. In the present study, we described the mutations of 42 tryptophan metabolism-related genes (TRPGs) in HCC cohorts. Then, HCC patients were well distributed into two subtypes based on the expression profiles of the 42 TRPGs. The clinicopathological characteristics and tumor microenvironmental landscape of the two subtypes were profiled. We also established a TRPGs scoring system and identified four hallmark TRPGs, including ACSL3, ADH1B, ALDH2, and HADHA. Univariate and multivariate Cox regression analysis revealed that the TRPG signature was an independent prognostic indicator for HCC patients. Besides, the predictive accuracy of the TRPG signature was assessed by the receiver operating characteristic curve (ROC) analysis. These results showed that the TRPG risk model had an excellent capability in predicting survival in both TCGA and GEO HCC cohorts. Moreover, we discovered that the TRPG signature was significantly related to the different immune infiltration and therapeutic drug sensitivity. The functional experiments and immunohistochemistry staining analysis also validated the results above. Our comprehensive analysis enhanced our understanding of TRPGs in HCC. A novel predictive model based on TRPGs was built, which may be considered as a beneficial tool for predicting the clinical outcomes of HCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansTryptophanPrognosisImmunotherapyAldehyde Dehydrogenase, Mitochondrial

Stichwörter der Autor:innen

hepatocellular carcinomaimmunotherapeutic responsespredicting prognosistryptophan metabolismtumor microenvironment

Substanzen

TryptophanALDH2 protein, humanAldehyde Dehydrogenase, Mitochondrial

Autor:innen und Institutionen

  • Department of Liver Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
  • Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong, China.
  • Department of Gastroenterology, The Second Hospital of Zhuzhou, Zhuzhou 412005, Hunan, China.

Zitieren

APA

Long, G., Wang, D., Tang, J., & Tang, W. (2023). Development of tryptophan metabolism patterns to predict prognosis and immunotherapeutic responses in hepatocellular carcinoma. Aging. https://doi.org/10.18632/aging.204928

Vancouver

Long G, Wang D, Tang J, Tang W. Development of tryptophan metabolism patterns to predict prognosis and immunotherapeutic responses in hepatocellular carcinoma. Aging. 2023. doi:10.18632/aging.204928

BibTeX
@article{Long2023,
  author = {Long, Guo and Wang, Dong and Tang, Jianing and Tang, Weifeng},
  title = {Development of tryptophan metabolism patterns to predict prognosis and immunotherapeutic responses in hepatocellular carcinoma},
  journal = {Aging},
  year = {2023},
  doi = {10.18632/aging.204928}
}
Kostenlos starten →